The four silent killers that take hold after 40

Ricardo is 52. An executive, he has had an annual checkup for twelve years, at the same lab, with the same physician. Every test always inside the reference range. I'm fine, he would say as he stood up from the visit. On a March morning, on the way to work, he felt the chest pressure that would change his life. Heart attack. Emergency catheterization. Stent. He was lucky the ambulance arrived in twenty minutes.

When he came back to the longevity office, three months later, he had a single question: how? I was doing everything right. I asked for the old labs again, and asked for others. ApoB of 118 mg/dL. Lp(a) of 87 nmol/L. Fasting insulin of 14 µIU/mL. hs-CRP of 3.4 mg/L. Homocysteine 12. Coronary calcium score never ordered. None of those numbers was new. They had been available in his labs for nearly a decade — except no one asked for them.

Ricardo was not negligent. He was the victim of a checkup model designed to find established disease, not risk in the making. And what was killing him from the inside — silently, for more than ten years — were four processes advancing at once.

Four diseases, one pattern

The epidemiologic literature is monotonously clear. Four categories dominate adult mortality in the Western world after 40: cardiovascular disease, metabolic disease, cancer, and neurodegenerative disease. Together, they account for the vast majority of premature deaths. Peter Attia, in Outlive, called them the “Horsemen of the Apocalypse” of longevity.

And there is something that unites the four: none of them appears suddenly. Each has a silent phase that lasts, on average, 10 to 20 years before the first symptom. Each has biomarkers that anticipate the problem. And each shares biological roots with the other three — insulin resistance, low-grade chronic inflammation, metabolic dysfunction. They are not four independent diseases. They are four manifestations of the same terrain.

Cardiovascular — the fire no one sees

The popular image of atherosclerosis — fat stuck to the artery wall — is intuitive and wrong. Atherosclerosis is, at its core, a chronic inflammatory disease. ApoB-containing particles (LDL is the most common) cross the endothelium, oxidize, are swallowed by macrophages, form foam cells, form plaque.

The process begins early. The PESA study (Progression of Early Subclinical Atherosclerosis), conducted by Valentín Fuster's group and published in 2021 in the Journal of the American College of Cardiology as a JACC Focus Seminar, followed 4,184 asymptomatic Spanish adults between 40 and 55 years old. Subclinical atherosclerosis was present in 63% of them — 71% in men, 48% in women. In 41%, the disease was intermediate or generalized. People who considered themselves healthy, with “normal” cholesterol, living their lives — while the plaques grew.

And there is an additional biological betrayal: the arteries expand to accommodate the plaque (positive remodeling). The lumen remains nearly unchanged. Blood flows. The treadmill stress test reads normal. Until an inflamed plaque, with a thin fibrous cap — and not necessarily the largest one — ruptures, exposes its content, and the clot blocks everything.

Plaques with less than 50% obstruction can kill. Plaques with 90% may never rupture. The conventional checkup looks for obstruction. The disease is inflammation.

Metabolic — the soil where everything germinates

If atherosclerosis is the fire, the gasoline-soaked terrain is insulin resistance. Cells stop responding to the insulin signal; the pancreas shouts louder, produces more insulin, and that compensatory hyperinsulinemia keeps glucose normal — for now.

Routine labs measure glucose, not insulin. That is why the diabetes diagnosis arrives as a surprise, after a decade of silent hyperinsulinemia. By the time glucose finally climbs, the pancreas is already exhausted, and the metabolic damage — inflamed endothelium, fatty liver, accumulated visceral fat, atherogenic lipid profile, elevated blood pressure — is already years ahead.

And it is not only obesity. There is the TOFI phenotype (Thin Outside, Fat Inside) — thin on the outside, fat on the inside. Normal BMI, but visceral fat accumulated around liver, pancreas, gut, heart. An estimated 10 to 20% of adults with normal BMI sit in this profile — and they are rarely investigated, because they “don't look” like they have a problem. Fasting insulin, HOMA-IR, and the triglycerides/HDL ratio together cost less than a few dollars and give the reading the scale never gives.

Neurodegeneration — Alzheimer's begins at 50

Of the four, this is the one that most terrifies, and the least understood. The brain changes that lead to Alzheimer's begin to accumulate 15 to 20 years before the first cognitive symptom. By the time someone in their 70s receives a diagnosis of mild cognitive impairment, the beta-amyloid plaques and tau tangles have been depositing since their 50s — or earlier.

The line of evidence that has grown most over the last two decades is the metabolic link. The review by Suzanne de la Monte and Jack Wands, published in 2008 in the Journal of Diabetes Science and Technology, proposed the term "type 3 diabetes" to describe what is seen in Alzheimer's brains: reduced insulin signaling, lower receptor activity, insulin resistance localized in brain tissue — even in patients without systemic diabetes. The brain becomes starved of energy, mitochondria enter dysfunction, tau hyperphosphorylates, beta-amyloid accumulates, microglia inflame.

Add sleep. During deep sleep, the brain's glymphatic system removes metabolic waste — including beta-amyloid itself. Years of fragmented sleep = incomplete clearance = accumulation. Add systemic inflammation that crosses the blood-brain barrier. Add sedentary behavior, which lowers BDNF and cerebral flow. Add chronic cortisol, directly toxic to the hippocampus.

It is the same terrain that feeds the cardiovascular and the metabolic. The diseases are not separate. They are different perspectives on the same phenomenon.

Cancer — when the terrain matters more than the seed

In 2016, in the New England Journal of Medicine, the working group of the International Agency for Research on Cancer (IARC), led by Lauby-Secretan, synthesized the evidence: excess body fat is associated with at least 13 types of cancer — esophagus (adenocarcinoma), post-menopausal breast, colon and rectum, endometrium, gallbladder, gastric cardia, kidney, liver, ovary, pancreas, thyroid, meningioma, and multiple myeloma. Subsequent studies have expanded the list to more than 30.

But obesity is not the mechanism. The mechanism is what it does to the internal environment. Chronic hyperinsulinemia activates the PI3K/Akt/mTOR pathway — one of the cascades most frequently altered in human tumors — promotes cell proliferation, inhibits programmed cell death. Chronic inflammation from the cytokines released by visceral fat favors angiogenesis and suppresses immune surveillance. Hormonal dysregulation — adipose tissue converts androgens into estrogens, raises the free fraction by reducing SHBG, feeds hormone-dependent tissues.

Screening (mammography, colonoscopy, contextualized PSA) matters and saves lives. But screening is detecting disease that is already there. Prevention is modifying the terrain before it appears. And the terrain is the same as that of the cardiovascular, the metabolic, the neurodegenerative.

The window 90% of people miss

If the four diseases share roots, the good news is direct: preventive actions converge. Controlling insulin resistance protects heart, brain, and reduces oncologic risk. Maintaining lean mass protects metabolism, function, bones, and appears to reduce cancer mortality. Regular deep sleep clears the brain and reduces systemic inflammation. Strength training and Zone 2 — combined — act on all three fronts simultaneously.

The window exists. It opens decades before the conventional diagnosis. James Fries, in 1980, in the NEJM, described what he called “compression of morbidity”: pushing the onset of disease closer to the end of life, shortening the period of decline. The theoretical concept of 1980 today has practical instruments for implementation — biomarkers, imaging, wearables, interventions with solid evidence.

What is missing, in Brazilian assistance medicine, is someone looking at the right numbers at the right time, with time to discuss trajectory, and the capacity to coordinate nutrition, strength, sleep, emotional regulation, and metabolic control in the same plan.

The minimum panel for the four

For any adult between 40 and 60, asymptomatic, these tests are worth every penny:

• ApoB and Lp(a) (Lp(a) once in a lifetime) — they replace total cholesterol as a reading of atherosclerotic risk
• Fasting insulin + HOMA-IR + triglycerides/HDL ratio — they read insulin resistance before glucose climbs
• HbA1c, fasting glucose
• hs-CRP — reading of systemic inflammation
• Homocysteine and B12 — vascular and cognitive risk
• Ferritin + transferrin saturation, vitamin D, magnesium
• TSH, free T4, free T3
• Free testosterone + SHBG (men), estradiol + FSH (women)
• Coronary artery calcium (CAC) score — once, decisive for stratifying the next decade
• Body composition by DEXA + bone densitometry — visceral fat and lean mass the scale does not see
• Polysomnography if there is suspicion of apnea (snoring, daytime sleepiness, unexplained fatigue)

And the reading together. Not in scattered snapshots, in isolated requests. In a panel.

The reading the Continuum makes

Continuum Plenya was designed for that window. The Plenya Score — over 800 items spanning history, symptoms, labs, and habits — is a way of making the trajectory visible, not the point. Physician, nutritionist, psychologist, and exercise physiologist operate as a single team, updating the plan every three to six months. Hormone replacement when indicated, strength training always, continuous metabolic adjustment, sleep and stress regulation as pillars — not as secondary items.

The Ricardo from the beginning of the story came back a year after the event. ApoB dropped to 68 with statin and adjusted diet. Lp(a) — which is hereditary and does not fall with anything — required even more aggressive control of every other factor. Fasting insulin returned to 6. He trains strength three times a week, does Zone 2 four times, sleeps well, lost 11 kg (24 lbs) of visceral fat. I didn't know it was possible to feel this way at 53, he said at follow-up. It is the sentence I hear most.

The four killers only beat those who ignore them. Late diagnosis is the point at which the body can no longer compensate — not the point at which the disease began. The window that separates reactive medicine from anticipatory medicine exists. It is measured in decades. And it is open right now, for those reading this.